Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Runali Sankhe, Manas Kinra, Jayesh Mudgal, Devinder Arora & Madhavan Nampoothiri. (2020) Neprilysin, the kidney brush border neutral proteinase: a possible potential target for ischemic renal injury. Toxicology Mechanisms and Methods 30:2, pages 88-99.
Read now
Read now
Articles from other publishers (19)
Shubhangi Saxena, Neha Dagar, Vishwadeep Shelke, Maciej Lech, Pragyanshu Khare & Anil Bhanudas Gaikwad. (2023) Metabolic reprogramming: Unveiling the therapeutic potential of targeted therapies against kidney disease. Drug Discovery Today 28:11, pages 103765.
Crossref
Crossref
Dario Roccatello, Hui-Yao Lan, Savino Sciascia, Sanjeev Sethi, Alessia Fornoni & Richard Glassock. (2023) From inflammation to renal fibrosis: A one-way road in autoimmunity?. Autoimmunity Reviews, pages 103466.
Crossref
Crossref
Jia Li, Dongwei Liu, Jingjing Ren, Guangpu Li, Zihao Zhao, Huanhuan Zhao, Qianqian Yan, Jiayu Duan & Zhangsuo Liu. (2023) Integrated analysis of RNA methylation regulators crosstalk and immune infiltration for predictive and personalized therapy of diabetic nephropathy. Human Genomics 17:1.
Crossref
Crossref
Collin Vandemark, Jimmy Nguyen & Zhi-Qing Zhao. (2023) Cardiovascular Protection with a Long-Acting GLP-1 Receptor Agonist Liraglutide: An Experimental Update. Molecules 28:3, pages 1369.
Crossref
Crossref
Matthieu Ariza, Steven Martin, Mikaël Dusenne, David Darmon & Matthieu Schuers. (2023) Management of patients with chronic kidney disease: a French medical centre database analysis. Family Practice.
Crossref
Crossref
Alberto Ortiz, Charles J Ferro, Olga Balafa, Michel Burnier, Robert Ekart, Jean-Michel Halimi, Reinhold Kreutz, Patrick B Mark, Alexandre Persu, Patrick Rossignol, Luis M Ruilope, Roland E Schmieder, Jose M Valdivielso, Lucia del Vecchio, Carmine Zoccali, Francesca Mallamaci & Pantelis Sarafidis. (2023) Mineralocorticoid receptor antagonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. Nephrology Dialysis Transplantation 38:1, pages 10-25.
Crossref
Crossref
Marco Simonini & Giuseppe Vezzoli. (2022) New Landmarks to Slow the Progression of Chronic Kidney Disease. Journal of Clinical Medicine 12:1, pages 2.
Crossref
Crossref
Zhiyue Zhu, Qi Zhang, Le Liu, Pengjie Bao, Shilin Liu, Chaoqun Song, Wenbo Yang & Zheng Nan. (2022) Clinical efficacy and safety of astragalus injection combined with ACEI/ARB in the treatment of diabetic kidney disease: Protocol for a systematic review and meta-analysis. Medicine 101:49, pages e31490.
Crossref
Crossref
Javier Donate-Correa, María Dolores Sanchez-Niño, Ainhoa González-Luis, Carla Ferri, Alberto Martín-Olivera, Ernesto Martín-Núñez, Beatriz Fernandez-Fernandez, Víctor G Tagua, Carmen Mora-Fernández, Alberto Ortiz & Juan F Navarro-González. (2022) Repurposing drugs for highly prevalent diseases: pentoxifylline, an old drug and a new opportunity for diabetic kidney disease. Clinical Kidney Journal 15:12, pages 2200-2213.
Crossref
Crossref
Chen-Ting Hung, Yi-Wei Tsai, Yu-Shuo Wu, Chih-Fan Yeh & Kai-Chien Yang. (2022) The novel role of ER protein TXNDC5 in the pathogenesis of organ fibrosis: mechanistic insights and therapeutic implications. Journal of Biomedical Science 29:1.
Crossref
Crossref
Marina P. C. Maires, Krislley R. Pereira, Everidiene K. V. B. Silva, Victor H. R. Souza, Flavio Teles, Paulyana F. Barbosa, Margoth R. Garnica, Felipe M. Ornellas, Irene L. Noronha & Camilla Fanelli. (2022) Synergic Renoprotective Effects of Combined ASC Therapy with RAAS Blockade in Experimental Advanced CKD. Stem Cells International 2022, pages 1-20.
Crossref
Crossref
William T.H. Lim, Ean H. Ooi, Ji J. Foo, Kwan H. Ng, Jeannie H.D. Wong & Sook S. Leong. (2021) Shear Wave Elastography: A Review on the Confounding Factors and Their Potential Mitigation in Detecting Chronic Kidney Disease. Ultrasound in Medicine & Biology 47:8, pages 2033-2047.
Crossref
Crossref
Elena Cantero-Navarro, Beatriz Fernández-Fernández, Adrian M. Ramos, Sandra Rayego-Mateos, Raúl R. Rodrigues-Diez, María Dolores Sánchez-Niño, Ana B. Sanz, Marta Ruiz-Ortega & Alberto Ortiz. (2021) Renin-angiotensin system and inflammation update. Molecular and Cellular Endocrinology 529, pages 111254.
Crossref
Crossref
Bao-Yi Shao, Shao-Fei Zhang, Hai-Di Li, Xiao-Ming Meng & Hai-Yong Chen. (2021) Epigenetics and Inflammation in Diabetic Nephropathy. Frontiers in Physiology 12.
Crossref
Crossref
M. M. Batiushin. (2020) Chronic Kidney Disease: Current State of the Problem. Rational Pharmacotherapy in Cardiology 16:6, pages 938-947.
Crossref
Crossref
A. O. Shpakov & E. V. Kaznacheyeva. (2020) Molecular Mechanisms of Apoptosis of Glomerular Podocytes in Diabetic Nephropathy. Biochemistry (Moscow), Supplement Series A: Membrane and Cell Biology 14:3, pages 205-222.
Crossref
Crossref
Marta Ruiz-Ortega, Sandra Rayego-Mateos, Santiago Lamas, Alberto Ortiz & Raul R. Rodrigues-Diez. (2020) Targeting the progression of chronic kidney disease. Nature Reviews Nephrology 16:5, pages 269-288.
Crossref
Crossref
Feng Bai, Li-Hui Zhang, Wei-Wei Zhang, Rong-Hua Zheng, Joshua Robert Eskew, Josiah Bennett, Ning-Ping Wang, Himangshu S. Bose & Zhi-Qing Zhao. (2020) Conservation of glucagon like peptide-1 level with liraglutide and linagilptin protects the kidney against angiotensin II-induced tissue fibrosis in rats. European Journal of Pharmacology 867, pages 172844.
Crossref
Crossref
Mehmet Kanbay, Sezen Yilmaz, Neris Dincer, Alberto Ortiz, Alan A Sag, Adrian Covic, Laura G Sánchez-Lozada, Miguel A Lanaspa, David Z I Cherney, Richard J Johnson & Baris Afsar. (2019) Antidiuretic Hormone and Serum Osmolarity Physiology and Related Outcomes: What Is Old, What Is New, and What Is Unknown?. The Journal of Clinical Endocrinology & Metabolism 104:11, pages 5406-5420.
Crossref
Crossref